Abstract
The recent recommendation by the World Health organization for the use of the dapivirine vaginal ring as a promising safe, efficacious and alternate choice for HIV prevention among women at significant risk of infection presents a welcome development for countries hard hit by HIV especially those in Sub-Saharan Africa. In Namibia, there is paucity of evidence on whether this novel HIV prevention strategy would be acceptable among those women at elevated risk of acquiring the virus. This paper provides a discourse on the opportunities and potential challenges in introducing the dapivirine vaginal ring on a large scale in the country.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
